Question 1

Has Kelley Cassens, APRN received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $930 in general payments to Kelley Cassens, APRN across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Kelley Cassens, APRN did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Kelley Cassens, APRN come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	21	$275
Otsuka America Pharmaceutical, Inc.	14	$170
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$104
Alkermes, Inc.	4	$99
E.r. Squibb & Sons, L.L.C.	3	$79
Neurocrine Biosciences, Inc.	3	$48
Johnson & Johnson	2	$32
Vertical Pharmaceuticals, LLC	1	$26
Vanda Pharmaceuticals Inc.	1	$25
Teva Pharmaceuticals USA, Inc.	1	$25
Axsome Therapeutics, Inc.	1	$25
Supernus Pharmaceuticals, Inc.	1	$22

Kelley Cassens, APRN

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other psychiatric/mental health in Saint Louis